Krystal L Edwards

Summary

Affiliation: Texas Tech University Health Sciences Center
Country: USA

Publications

  1. doi request reprint Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
    Krystal L Edwards
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75216, USA
    Pharmacotherapy 30:955-65. 2010
  2. ncbi request reprint Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes
    Krystal L Edwards
    Department of Pharmacy Practice, Ambulatory Care Division, School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX, USA
    J Pharm Pract . 2016
  3. ncbi request reprint An update in incretin-based therapy: a focus on glucagon-like peptide-1 receptor agonists
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75216, USA
    Diabetes Technol Ther 14:951-67. 2012
  4. doi request reprint Third-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Department of Pharmacy Practice, Veterans Administration North Texas Health Care System, Dallas, TX 75216, USA
    Pharmacotherapy 28:506-21. 2008
  5. doi request reprint Race as a factor for intensification of diabetes medications
    Katura C Bullock
    Texas Tech University Health Sciences Center, School of Pharmacy Dallas Fort Worth, 4500 S Lancaster Rd, Building 7 R 119A, Dallas, TX 75216, USA
    Diabetes Educ 39:335-43. 2013
  6. pmc Ranolazine for the treatment of refractory angina in a veterans population
    R Shane Greene
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    Cardiovasc Revasc Med 13:141.e1-5. 2012
  7. ncbi request reprint Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430 8162, USA
    Pharmacotherapy 26:168-81. 2006
  8. ncbi request reprint Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
    Carlos A Alvarez
    Texas Tech University Health Sciences Center, School of Pharmacy DFW Campus Department of Pharmacy Practice, 4500 S Lancaster Rd, Bldg 7 R 119A, Dallas, TX 75216 USA and North Texas Veterans Affairs, Dallas, TX USA
    J Clin Lipidol 2:447-52. 2008
  9. ncbi request reprint An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors
    Brian K Irons
    Ambulatory Care Texas Tech University Health Sciences Center, School of Pharmacy, 3601 4th St Lubbock, TX 79430, USA
    Curr Diabetes Rev 8:169-82. 2012
  10. ncbi request reprint A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia
    Lisa M Chastain
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Ft Worth Regional Campus, 4500 S Lancaster Road, Building 7, Dallas, TX 75216, USA North Texas Veterans Affairs Health Care Systems, Dallas, TX 75216, USA
    J Clin Lipidol 1:634-9. 2007

Collaborators

Detail Information

Publications10

  1. doi request reprint Insulin glargine and cancer risk: an opinion statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
    Krystal L Edwards
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75216, USA
    Pharmacotherapy 30:955-65. 2010
    ..Until more substantial data are available, however, neither the choice of initial insulin therapy nor insulin maintenance regimens should be influenced by the current information linking insulin glargine to cancer...
  2. ncbi request reprint Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes
    Krystal L Edwards
    Department of Pharmacy Practice, Ambulatory Care Division, School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, TX, USA
    J Pharm Pract . 2016
    ..To show that clinical pharmacy specialists (CPSs) can be utilized in remote facilities to provide appropriate diabetes outcomes along with potential cost savings...
  3. ncbi request reprint An update in incretin-based therapy: a focus on glucagon-like peptide-1 receptor agonists
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75216, USA
    Diabetes Technol Ther 14:951-67. 2012
    ..For T2DM patients willing to use an injectable agent, exenatide and liraglutide offer another therapeutic option to control hyperglycemia with the potential for weight loss and may be combined with other agents safely...
  4. doi request reprint Third-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin
    Krystal L Edwards
    School of Pharmacy, Texas Tech University Health Sciences Center, Department of Pharmacy Practice, Veterans Administration North Texas Health Care System, Dallas, TX 75216, USA
    Pharmacotherapy 28:506-21. 2008
    ..Therefore, a standard of care cannot be provided; rather, clinicians must evaluate each patient to ascertain that patient's optimum therapy. In doing so, clinicians need to be familiar with the efficacy, safety, and cost of each agent...
  5. doi request reprint Race as a factor for intensification of diabetes medications
    Katura C Bullock
    Texas Tech University Health Sciences Center, School of Pharmacy Dallas Fort Worth, 4500 S Lancaster Rd, Building 7 R 119A, Dallas, TX 75216, USA
    Diabetes Educ 39:335-43. 2013
    ..The purpose of this study was to investigate if patients of nonwhite race are less likely to receive insulin therapy for treatment of poorly controlled diabetes than patients of white race...
  6. pmc Ranolazine for the treatment of refractory angina in a veterans population
    R Shane Greene
    Veterans Affairs North Texas Health Care System, Dallas, TX 75216, USA
    Cardiovasc Revasc Med 13:141.e1-5. 2012
    ..This case series describes the use of ranolazine for the treatment of chronic stable angina refractory to maximal medical treatment in a veterans population...
  7. ncbi request reprint Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Brian K Irons
    Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430 8162, USA
    Pharmacotherapy 26:168-81. 2006
    ..Alterations in these risk factors are likely due to their effects on improving insulin sensitivity and/or glycemic control. Trials to assess whether thiazolidinediones actually reduce cardiovascular outcomes are continuing...
  8. ncbi request reprint Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
    Carlos A Alvarez
    Texas Tech University Health Sciences Center, School of Pharmacy DFW Campus Department of Pharmacy Practice, 4500 S Lancaster Rd, Bldg 7 R 119A, Dallas, TX 75216 USA and North Texas Veterans Affairs, Dallas, TX USA
    J Clin Lipidol 2:447-52. 2008
    ..Recent reports demonstrate a paradoxic decrease in high-density lipoprotein cholesterol (HDL-C) with thiazolidinedione (TZD) and fibrate combination therapy...
  9. ncbi request reprint An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors
    Brian K Irons
    Ambulatory Care Texas Tech University Health Sciences Center, School of Pharmacy, 3601 4th St Lubbock, TX 79430, USA
    Curr Diabetes Rev 8:169-82. 2012
    ..For patients with mildly elevated glucose concentrations, they are therapeutic options in both drug-naive patients as well as those not optimally controlled on other diabetes medications...
  10. ncbi request reprint A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia
    Lisa M Chastain
    Texas Tech University Health Sciences Center School of Pharmacy, Dallas Ft Worth Regional Campus, 4500 S Lancaster Road, Building 7, Dallas, TX 75216, USA North Texas Veterans Affairs Health Care Systems, Dallas, TX 75216, USA
    J Clin Lipidol 1:634-9. 2007
    ..Abnormalities in lipid metabolism are a well-described consequence of human immunodeficiency virus (HIV) infection being treated with highly active antiretroviral therapies (HAART)...